I study children with stroke, and try to understand the mechanisms behind why children have strokes. Specifically, I investigate the potential of hypercoagulable and inflammatory biomarkers in prognosticating outcome and recurrence in childhood-onset arterial ischemic stroke.
For Referring Providers:
We are trying to use special global assays to ascertain which patients are at higher risk for recurrent stroke after their initial event. In addition, I'm interested in studying classification of childhood stroke since childhood stroke is a rare disease. All efforts to determine risk factors, treatments and outcomes need to be multicenter, therefore having a well validated and reliable classification system is imperative in studying this disease.